Review article: The management of acute variceal bleeding

Alimentary Pharmacology and Therapeutics

Volumn 18, Issue 3, 2003, Pages 253-262

  Ferguson, J W ^a   Tripathi, D ^a   Hayes, P C ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFTRIAXONE; CILASTATIN; CIPROFLOXACIN; COLISTIN; CYANOACRYLATE; GENTAMICIN; GLYCERYL TRINITRATE; IMIPENEM; NEOMYCIN; NORFLOXACIN; NYSTATIN; OCTREOTIDE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SOMATOSTATIN; TERLIPRESSIN; THROMBIN; VANCOMYCIN; VAPREOTIDE; VASOPRESSIN;

ALGORITHM; ANTIBIOTIC THERAPY; CLINICAL TRIAL; ENDOSCOPY; ESOPHAGUS VARICES BLEEDING; HEART INFARCTION; HUMAN; ISCHEMIA; LIGATION; LIVER CIRRHOSIS; MESENTERY; MORTALITY; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RESUSCITATION; REVIEW; SCLEROTHERAPY; SPLANCHNIC BLOOD FLOW; STENT; STOMACH VARICES;

ACUTE DISEASE; BALLOON DILATATION; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEMOSTATICS; HORMONES; HUMANS; LIGATION; LYSINE VASOPRESSIN; OCTREOTIDE; PORTASYSTEMIC SHUNT, SURGICAL; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; SCLEROTHERAPY; SOMATOSTATIN; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 0041823995     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01664.x     Document Type: Review

References (96)

1. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-54.
2. Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999; 29: 1655-61.
3. Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995; 346: 865-8.
4. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988; 319: 983-9.
5. Luca A, Cirera I, Garcia-Pagan JC, et al. Hemodynamic effects of acute changes in intra-abdominal pressure in patients with cirrhosis. Gastroenterology 1993; 104: 222-7.
6. Luca A, Garcia-Pagan JC, Bosch J, et al. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 1997; 112: 1284-9.
7. McCormick PA, Dick R, Graffeo M, et al. The effect of non-protein liquid meals on the hepatic venous pressure gradient in patients with cirrhosis. J Hepatol 1990; 11: 221-5.
8. Beppu K, Inokuchi K, Koyanagi N, et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27: 213-8.
9. Perello A, Escorsell A, Bru C, et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology 1999; 30: 1393-7.
10. Boyer TD, Triger DR, Horisawa M, Redeker AG, Reynolds TB. Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure. Gastroenterology 1977; 72: 584-9.
11. Feu F, Garcia-Pagan JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995; 346: 1056-9.
12. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Br Soc Gastroenterol Gut 2000; 46: III1-III15.
13. Vlavianos P, Mac MP, Williams R, Westaby D. Splanchnic and systemic haemodynamic response to Volume changes in patients with cirrhosis and portal hypertension. Clin Sci (Lond) 1999; 96: 475-81.
14. Kravetz D, Bosch J, Arderiu M, Pizcueta MP, Rodes J. Hemodynamic effects of blood volume restitution following a. hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting. Hepatology 1989; 9: 808-14.
15. Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 1995; 108: 1828-34.
16. Blaise M, Pateron D, Trinchet JC, Levacher S, Beaugrand M, Pourriat JL. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1994; 20: 34-8.
17. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1998; 27: 1207-12.
18. Soares-Weiser K, Brezis M, Tur-Kaspa R, Leibovici L. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002; 2: CD002907.
19. Cales P, Masliah C, Bernard B, et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. French Club for Study Portal Hypertension. N Engl J Med 2001; 344: 23-8.
20. Avgerinos A, Nevens F, Raptis S, et al. Early administration of somatostatin and efficacy of sclerotherapy in acure oesophageal variceal bleeds: the European acute bleeding oesophageal variceal episodes (ABOVE) randomised trial. Lancet 1997; 350: 1495-9.
21. The Copenhagen Esophageal Varices Sclerotherapy Project. Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. N Engl J Med 1984; 311: 1594-600.
22. Barsoum MS, Bolous FI, Elrooby AA, Rizkallah MA, Ibrahim AS. Tamponade and injection sclerotherapy in the management of bleeding esophageal varices. Br J Surg 1982; 69: 76-8.
23. Moreto M, Zaballa M, Bernal A, Ibanez S, Ojembarrena E, Rodriguez A. A randomized trial of tamponade or sclerotherapy as immediate treatment for bleeding esophageal varices. Surg Gynecol Obstet 1988; 167: 331-4.
24. Paquet KJ, Feussner H. Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlIed randomized trial. Hepatology 1985; 5: 580-3.
25. D'Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus medical interventions for bleeding oesophageal varices in cirrhotic patients. Cochrane Database Syst Rev 2002; 1: CD002233.
26. Helmy A, Hayes PC. Review article: current endoscopic therapeutic options in the management of variceal bleeding. Aliment Pharmacol Ther 2001; 15: 575-94.
27. Van Stiegmann G, Cambre T, Sun JH. A new endoscopic elastic band ligating device. Gastrointest Endosc 1986; 32: 230-3.
28. Gross M, Schiemann U, Muhlhofer A, Zoller WG. Meta-analysis: efficacy of therapeutic regimens in ongoing variceal bleeding. Endoscopy 2001; 33: 737-46.
29. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995; 123: 280-7.
30. Sung JJ, Chung SC, Yung MY, et al. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995; 346: 1666-9.
31. Conn HO, Storer EH, et al. Intra-arterial vasopressin in the treatment of upper GI haemorrhage: a prospective controlled trial. Gastroenterology 1975; 68: 211-21.
32. Mallory A, Schaefer JW, Cohen JR, Holt SA, Norton LW. Selective intra-arterial vasopression in fusion for upper gastrointestinal tract hemorrhage: a controlled trial. Arch Surg 1980; 115: 30-2.
33. Merigan TC, Plotkin GR, Davidson CS. Effect of IV administered posterior pitiutary extract on hemmorhage from bleeding oesophageal varices. N Engl J Med 1962; 266: 134-5.
34. Fogel MR, Knauer CM, Andres LL, et al. Continuous intravenous vasopression in fusion for upper gastrointestinal tract bleeding. A placebo-controlled trial. Ann Int Med 1982; 96: 565-9.
35. Bosch J, Groszmann RJ, Garcia-Pagan JC, et al. Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial. Hepatology 1989; 10: 962-8.
36. Tsai YT, Lay CS, Lai KH, et al. Controlled trial of vasopressin plus nitroglycerin vs. vasporessin alone in the treatment alone in the treatment of bleeding esophageal varices. Hepatology 1986; 6: 406-9.
37. Westaby D, Gimson A, Hayes PC, Williams R. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension. Gut 1988; 29: 372-7.
38. Garcia-Pagan JC, Escorsell A, Moitinho E, Bosch J. Influence of pharmacological agents on portal hemodynamics: basis for its use in the treatment of portal hypertension. Semin Liver Dis 1999; 19: 427-38.
39. Brunati X, Ceriani R, Curioni R, et al. Sclerotherapy alone vs sclerotherapy plus terlipressin vs sclerotherapy plus octreotide in the treatment of acute variceal haemmorhage. Hepatology 1996; 24: 207A.
40. Freeman JG, Cobden I, Record CO. Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol 1989; 11: 58-60.
41. Patch D, Caplin M, Greenslade L, et al. Randomised double blind trial of 5 day terlipressin vs placebo in acute variceal haemorrhage. J Hepatol 1999; 30: 55.
42. Pauwels A, Florent C, Desaint B, Van Guivarch PH, Levy VG. Terlipressin and somatostatin in the treatment of hemorrhages from rupture of esophageal varices. Gastroenterol Clin Biol 1994; 18: 388-9.
43. Soderlund C, Magnusson I, Torngren S, Lundell L. Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 1990; 25: 622-30.
44. Walker S, Stiehl A, Raedsch R, Kommerell B. Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study. Hepatology 1986; 6: 112-5.
45. Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2001; 1: CD002147.
46. Escorsell A, Ruiz DA, Planas R, et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology 2000; 32: 471-6.
47. Feu F, Ruiz DA, Banares R, Planas R, Bosch J. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group. Gastroenterol 1996; 111: 1291-9.
48. Walker S, Kreichgauer HP, Bode JC. Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled, double-blind study. Hepatology 1992; 15: 1023-30.
49. Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology 1981; 80: 518-25.
50. Burroughs AK, McCormick PA, Hughes MD, Sprengers D, D'Heygere F, McIntyre N. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology 1990; 99: 1388-95.
51. Valenzuela JE, Schubert T, Fogel MR, et al. Multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology 1989; 10: 958-61.
52. Bagarani M, Albertini V, Anza M, et al. Effect of somatostatin in controlling bleeding from esophageal varices. Ital J Surg Sci 1987; 17: 21-6.
53. Hsai HC, Lee FY, Tsai YT. Comparison of somatostatin and vasopressin in the control of acute esophageal variceal hemorrhage. Chin J Gastroenterol 1990; 7: 71-8.
54. Rodriguez-Moreno F, Santolaria F, Glez-Reimers E, et al. A randomised trial of somatostatin vs vasopressin plus nitroglycerin in the treatment of acute variceal bleeding. Abstract. Hepatology 1991; 13: S162.
55. Saari A, Klvilaakso E, Inberg M, et al. Comparison of somatostatin and vasopressin in bleeding esophageal varices. Am J Gastroenterol 1990; 85: 804-7.
56. Jenkins SA, Baxter JN, Corbett W, et al. A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage. Br Med J (Clin Res Edn) 1985; 290: 275-8.
57. Kravetz D, Bosch J, Teres J, Bruix J, Rimola A, Rodes J. Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology 1984; 4: 442-6.
58. Jenkins SA, Shields R, Davies M, et al. Multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Gut 1997; 41: 526-33.
59. Burroughs AK. Double blind RCT of 5 day octreotide versus placebo, associated with sclerotherapy for trial/failures. Hepatology 1996; 24: 901.
60. Silvain C, Carpentier S, Sautereau D, et al. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology 1993; 18: 61-5.
61. Sung JJ, Chung SC, Lai CW, et al. Octreotide infusion or sclerotherapy for variceal haemorrhage. Lancet 1993; 342: 637-41.
62. Gotzsche PC, Gjorup I, Bonnen H, et al. Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis. Br Med J 1995; 310: 1495-8.
63. Banares R, Albillos A, Rincon D, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002; 35: 609-15.
64. Besson I, Ingrand P, Person B, et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995; 333: 550-60.
65. Ceriani R, Curioni R, Morini L, et al. Sclerotherapy alone (ES) vs. sclerotherapy plus terlipressin (EST) vs. sclerotherapy plus octreotide in the treatment of acute variceal bleeding. (Abstract) Gastroenterology 1997; 112: 1238A.
66. Signorelli S, Negrini F, Bonelli M, Girola M. Sclerotherapy with or without somatostatin or octreotide in the treatment of acute variceal haemorrhage: our experience. (Abstract) Gastroenterology 1996; 110: 1326A.
67. Signorelli S, Paris B, Negrini F, et al. Esophageal variceal bleeding: comparison between treatment with sclerotherapy alone vs sclerotherapy plus octreotide. (Abstract) Hepatology 1997; 26: 137A.
68. Zuberi BF, Baloch Q. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low risk cirrhosis. Am J Gastroenterol 2000; 95: 768-71.
69. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med 2001; 345: 669-81.
70. Gimson AE, Westaby D, Williams R. Endoscopic sclerotherapy in the management of gastric variceal haemorrhage. J Hepatol 1991; 13: 274-8.
71. Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 1986; 32: 264-8.
72. Sarin SK, Jain AK, Jain M, Gupta R. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 2002; 97: 1010-5.
73. Williams SG, Peters RA, Westaby D. Thrombin - an effective treatment for gastric variceal haemorrhage. Gut 1994; 35: 1287-9.
74. Barange K, Peron JM, Imani K, et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999; 30: 1139-43.
75. Tripathi D, Therapondos G, Jackson E, Redhead DN, Hayes PC. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002; 51: 270-4.
76. Stanley AJ, Jalan R, Ireland HM, Redhead DN, Bouchier IA, Hayes PC. A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther 1997; 11: 171-6.
77. Panes J, Teres J, Bosch J, Rodes J. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci 1988; 33: 454-9.
78. Willson PD, Kunkler R, Blair SD, Reynolds KW. Emergency oesophageal transection for uncontrolled variceal haemorrhage. Br J Surg 1994; 81: 992-5.
79. Jalan R, John TG, Redhead DN, et al. Comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol 1995; 90: 1932-7.
80. Burroughs AK, Hamilton G, Phillips A, Mezzanotte G, McIntyre N, Hobbs KE. A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med 1989; 321: 857-62.
81. Huizinga WK, Angorn IB, Baker LW. Esophageal transection versus injection sclerotherapy in the management of bleeding esophageal varices in patients at high risk. Surg Gynecol Obstet 1985; 160: 539-46.
82. Teres J, Baroni R, Bordas JM, Visa J, Pera C, Rodes J. Randomized trial of portacaval shunt, stapling transection and endoscopic sclerotherapy in uncontrolled variceal bleeding. J Hepatol 1987; 4: 159-67.
83. Adam R, Diamond T, Bismuth H. Partial portacaval shunt: renaissance of an old concept. Surgery 1992; 111: 610-6.
84. Darling RC III, Shah DM, Chang BB, Thompson PN. Leather RP. Long-term follow-up of poor-risk patients undergoing small-diameter portacaval shunts. Am J Surg 1992; 164: 225-7.
85. Rikkers LF, Jin G. Emergency shunt. Role in the present management of variceal bleeding. Arch Surg 1995; 130: 472-7.
86. Richter GM, Noeldge G, Palmaz JC, et al. Transjugular intrahepatic portacaval stent shunt. Preliminary clinical results. Radiology 1990; 174: 1027-30.
87. Rossle M, Richter GM, Noldge G, et al. Performance of an intrahepatic portacaval shunt (PCS) using a catheter technique. A case report. Hepatology 1988; 8: 1348.
88. Sanyal AJ, Freedman AM, Luketic VA, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996; 111: 138-46.
89. Hsieh WJ, Lin HC, Hwang SJ, et al. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol 1998; 93: 962-6.
90. Pauwels A, Mostefa-Kara N, Debenes B, Degoutte E, Levy VG. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology 1996; 24: 802-6.
91. Rimola A, Bory F, Teres J, Perez-Ayuso RM, Arroyo V, Rodes J. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985; 5: 463-7.
92. Rolando N, Gimson A, Philpott-Howard J, et al. Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis. J Hepatol 1993; 18: 290-4.
93. Selby WS, Norton ID, Pokorny CS, Benn RA, Bacteremia and bacterascites after endoscopic sclerotherapy for bleeding esophageal varices and prevention by intravenous cefotaxime: a randomized trial. Gastrointest Endosc 1994; 40: 680-4.
94. Soriano G, Guarner C, Tomas A, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992; 103: 1267-72.
95. Zacharof A, Petrogiannopoulos C, Soutos D, et al. Bacterial infection is prevented by ciprofloxacin in cirrhotics with gastrointestinal hemorrhage. Gut 1997; 41: A189 (Abstract).
96. Imperiale TF, Teran JC, McCullough AJ. A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage. Gastroenterology 1995; 109: 1289-94.